- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06713707
Investigation of Validity and Reliability of the Minnesota Manual Dexterity Test in Parkinson's Disease
January 24, 2025 updated by: Sefa Eldemir, Gazi University
Investigation of Validity and Reliability of the Minnesota Manual Dexterity Test in Patients with Parkinson's Disease
Parkinson's Disease (PD) is a disease that affects upper extremity functional skills with clinical findings such as bradykinesia, rigidity, and hypokinesia, and causes limitations in patients' daily life activities.
The impairment of upper extremity functional skills is related to the deficiency in planning both voluntary and complex movements, as well as the deficiency in multiple motor planning.
In particular; fine manual dexterity, reaching, and grasping movements are affected, greatly affecting patients' daily activities.
Therefore, upper extremity evaluations are an important issue to consider for training upper extremity motor skills in PD.
There are minimal assessment tools for evaluating the upper extremity functions of individuals with PD.
The Nine-Hole Peg Test and the Jebsen Hand Function Evaluation Test are the most commonly used scales in the evaluation of the upper extremity in PD, and their validity and reliability have been demonstrated.
These scales roughly evaluate both extremities separately.
However, these scales are not suitable assessment tools for testing activities in which both extremities are frequently used in daily life.
Therefore, there is a need for valid and reliable scales that can evaluate upper extremity activities both in isolation and bilaterally.
The Minnesota manual dexterity test (MMDT) allows both hands to be evaluated together.
It also evaluates hand-eye coordination and gross motor skills in addition to manual dexterity.
MMDT is used in individuals with PD, but there is no study in the literature examining the validity and reliability of the scale.
Therefore, this study aims to evaluate the reliability and validity of MMDT in individuals with PD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
At baseline, the MMDT, 9-hole peg test, and Jebsen-Taylor Hand Function Test (JTHFT) will be applied to the MS group.
The MMDT will be repeated seven days after the first application in MS.
Healthy controls are going to perform only the MMDT.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sivas/Center
-
Sivas, Sivas/Center, Turkey
- Sivas Cumhuriyet University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Patients with Parkinson's disease who apply to Sivas Cumhuriyet University, Department of Physiotherapy and Rehabilitation will be invited to this study.
Description
Inclusion Criteria:
- Between 40-80 years old
- Diagnosed with only "Parkinson's Disease" by a neurologist
- Between 1-3 values of your thoughts according to Hoehn and Yahr manufacturers
Exclusion Criteria:
- Having any vision, hearing or perception problems that may affect the research results,
- Having an orthopedic problem that may affect manual skills in the upper extremity,
- Having a cardiovascular, pulmonary disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Test Group
Patients with Parkinson's disease
|
Individuals who meet the inclusion criteria will be evaluated for manual dexterity using MMDT on a predetermined day.
Individuals who meet the inclusion criteria will be evaluated for manual dexterity using 9-HPT, and JTHFT.
|
|
Control Group
Healthy group
|
Individuals who meet the inclusion criteria will be evaluated for manual dexterity using MMDT on a predetermined day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Minnesota Manual Dexterity Test
Time Frame: baseline (on the predetermined assessment day)
|
The Minnesota Manual Dexterity Test (MMDT) is a performance test designed to evaluate hand functions and hand-eye coordination both unilaterally and bilaterally, higher scores mean a worse outcome
|
baseline (on the predetermined assessment day)
|
|
Minnesota Manual Dexterity Test-second
Time Frame: the second assessment will be conducted after the one week
|
The Minnesota Manual Dexterity Test (MMDT) is a performance test designed to evaluate hand functions and hand-eye coordination both unilaterally and bilaterally, higher scores mean a worse outcome
|
the second assessment will be conducted after the one week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
9-Hole Peg Test
Time Frame: baseline (on the predetermined assessment day)
|
The 9-Hole Peg Test (9-HPT) evaluates hand dexterity based on performance, higher scores mean a worse outcome
|
baseline (on the predetermined assessment day)
|
|
The Jebsen Hand Function Test
Time Frame: baseline (on the predetermined assessment day)
|
The Jebsen Hand Function Test (JHFT) is one of the objective and standardized tests that assesses fine motor skills and functional hand use by simulating daily living activities, higher scores mean a worse outcome
|
baseline (on the predetermined assessment day)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Mak MK, Lau ET, Tam VW, Woo CW, Yuen SK. Use of Jebsen Taylor Hand Function Test in evaluating the hand dexterity in people with Parkinson's disease. J Hand Ther. 2015 Oct-Dec;28(4):389-94; quiz 395. doi: 10.1016/j.jht.2015.05.002. Epub 2015 May 18.
- Earhart GM, Cavanaugh JT, Ellis T, Ford MP, Foreman KB, Dibble L. The 9-hole PEG test of upper extremity function: average values, test-retest reliability, and factors contributing to performance in people with Parkinson disease. J Neurol Phys Ther. 2011 Dec;35(4):157-63. doi: 10.1097/NPT.0b013e318235da08.
- Ovacik U, Tarakci E, Gungor F, Menengic KN, Leblebici G, Acar ZO, Soysal A. The minnesota manual dexterity test as a bimanual performance measure in people with multiple sclerosis. Mult Scler Relat Disord. 2022 Aug;64:103943. doi: 10.1016/j.msard.2022.103943. Epub 2022 Jun 6.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 28, 2024
Primary Completion (Actual)
January 10, 2025
Study Completion (Actual)
January 15, 2025
Study Registration Dates
First Submitted
November 27, 2024
First Submitted That Met QC Criteria
November 27, 2024
First Posted (Actual)
December 3, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 24, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7-PD-Minnesota-validity
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaNot yet recruitingParkinson Disease | PARKINSON DISEASE (Disorder) | Parkinson Disease (PD), Postural Balance
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
Clinical Trials on Manual Dexterity (only MMDT)
-
Gazi UniversityCumhuriyet UniversityCompleted
-
NYU Langone HealthCompleted
-
Universidad Catolica de TemucoUniversity of Valencia; Universidad de La FronteraNot yet recruitingImmobilization | Disuse AtrophyChile
-
Pamukkale UniversityCompleted
-
Institut de Myologie, FranceUnknownNeuromuscular DisordersFrance
-
Herlev HospitalCompleted
-
Centre Hospitalier St AnneInstitut National de la Santé Et de la Recherche Médicale, France; University...Unknown
-
Cliniques universitaires Saint-Luc- Université...Université Catholique de LouvainNot yet recruitingVirtual Reality | Brain | EEG | Manual Dexterity | fNIRSBelgium
-
Proaxis TherapyVirginia Commonwealth University; Arcadia University; National Athletic Trainers...CompletedShoulder Impingement SyndromeUnited States